(Q40511780)

21 September 2017

1 reference

title

Drug-induced torsade de pointes. Incidence, management and prevention (English)

1 reference

21 September 2017

T S Faber

1

1 reference

21 September 2017

M Zehender

series ordinal

2

1 reference

21 September 2017

H Just

series ordinal

3

1 reference

21 September 2017

publication date

1 December 1994

1 reference

21 September 2017

1 reference

21 September 2017

volume

11

1 reference

21 September 2017

issue

6

1 reference

21 September 2017

page(s)

463-476

1 reference

Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval

21 September 2017

cites work

1 reference

12 December 2020

Open clinical studies at a referral center: chronic maintenance tocainide therapy in patients with recurrent sustained ventricular tachycardia refractory to conventional antiarrhythmic agents

1 reference

12 December 2020

Sudden cardiac death while taking amiodarone therapy: the role of abnormal repolarization

1 reference

12 December 2020

UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.

1 reference

12 December 2020

Mechanism of the cardiotoxic actions of terfenadine

1 reference

12 December 2020

Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?

1 reference

12 December 2020

Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism

1 reference

12 December 2020

QT interval prolongation as predictor of sudden death in patients with myocardial infarction

1 reference

12 December 2020

Torsade de pointes due to quinidine: observations in 31 patients

1 reference

12 December 2020

1 reference

12 December 2020

Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports

1 reference

12 December 2020

The duration of the Q-U interval and its components in electrocardiograms of normal persons

1 reference

12 December 2020

Propafenone-Induced Torsade de Pointes: Cross-Reactivity with Quinidine

1 reference

12 December 2020

Proarrhythmic responses during electrophysiologic testing

1 reference

12 December 2020

Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment

1 reference

12 December 2020

QT and action potential duration

1 reference

12 December 2020

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

12 December 2020

QT prolongation and recurrent "torsades de pointes" during erythromycin lactobionate infusion

1 reference

12 December 2020

Ventricular arrhythmias and hypokalaemia

1 reference

12 December 2020

Antihypertensive compounds as antiarrhythmic agents: focus on beta-blocking drugs in ventricular arrhythmias

1 reference

12 December 2020

Amiodarone-induced ventricular fibrillation.

1 reference

12 December 2020

Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone

1 reference

12 December 2020

Pentamidine-induced torsade de pointes

1 reference

12 December 2020

Experimental models of torsades de pointes

1 reference

12 December 2020

Satalol-induced torsade de pointes

1 reference

12 December 2020

Amiodarone reduces QT dispersion in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Multiform ventricular tachycardia due to the interaction of aminophylline and halothane

1 reference

12 December 2020

Management of patients with malignant ventricular arrhythmias

1 reference

12 December 2020

Ventricular tachycardia associated with flecainide

1 reference

12 December 2020

Torsade de pointes: definitions, causative factors, and therapy: experience with sixteen patients

1 reference

12 December 2020

Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter

1 reference

12 December 2020

Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval

1 reference

12 December 2020

Polymorphous ventricular tachycardia associated with acute myocardial infarction

1 reference

12 December 2020

Pharmacology of the class 111 antiarrhythmic agent sematilide in patients with arrhythmias

1 reference

12 December 2020

Ventricular tachycardia with 2 variable opposing foci

1 reference

12 December 2020

Two cases of "torsades de pointe" following intravenous administration of suxamethonium to digitalized patients (author's transl)

1 reference

12 December 2020

QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

1 reference

12 December 2020

Recording of monophasic action potentials of the right ventricle in long QT syndromes complicated by severe ventricular arrhythmias

1 reference

12 December 2020

Amiodarone-induced polymorphous ventricular tachycardia

1 reference

12 December 2020

Thioridazine (mellaril)-induced ventricular tachycardia controlled with an artificial pacemaker

1 reference

12 December 2020

Sotalol, hypokalaemia, syncope, and torsade de pointes

1 reference

12 December 2020

Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide

1 reference

12 December 2020

Effects of procaine amide on the electrophysiologic properties of the canine ventricular conducting system

1 reference

12 December 2020

The time course of action potential repolarization affects delayed afterdepolarization amplitude in atrial fibers of the canine coronary sinus

1 reference

12 December 2020

Torsade de pointes after inhaled pentamidine

1 reference

12 December 2020

Torsades de pointes versus polymorphous ventricular tachycardia

1 reference

12 December 2020

The proarrhythmic effects of amiodarone

1 reference

12 December 2020

Propafenone--a new antiarrhythmic drug

1 reference

12 December 2020

Sotalol intoxication, two patients with concentration-effect relationships

1 reference

12 December 2020

Effects of thioridazine (Mellaril) on ventricular electrophysiologic properties

1 reference

12 December 2020

Quinidine-induced ventricular flutter and fibrillation without digitalis therapy

1 reference

12 December 2020

Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients

1 reference

12 December 2020

1 reference

12 December 2020

A case of sotalol poisoning

1 reference

12 December 2020

The ventricular gradient and repolarization

1 reference

12 December 2020

Electrophysiologic testing in patients with the long QT syndrome

1 reference

12 December 2020

Succinylcholine-induced cardiac arrhythmias

1 reference

12 December 2020

Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs

1 reference

12 December 2020

Polymorphous ventricular tachycardia: clinical features and treatment

1 reference

12 December 2020

A new chapter in electrocardiography: progressive variations in the amplitude of the electrocardiogram

1 reference

12 December 2020

Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure

1 reference

12 December 2020

1 reference

12 December 2020

"Torsades de pointes" and atrioventricular block

1 reference

12 December 2020

Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator

1 reference

12 December 2020

New Directions in the Development of Antiarrhythmic Drugs

1 reference

12 December 2020

Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers

1 reference

12 December 2020

Torsade de Pointe. Malignant cardiac arrhythmia induced by amantadine poisoning

1 reference

12 December 2020

Repolarization abnormalities in survivors of out-of-hospital ventricular fibrillation

1 reference

12 December 2020

Polymorphic ventricular tachycardia (Torsade de Pointes) associated with the use of probucol

1 reference

12 December 2020

Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes

1 reference

12 December 2020

Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome

1 reference

12 December 2020

Harmful interactions of amiodarone and class I anti-arrhythmia agents

1 reference

12 December 2020

Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin

1 reference

12 December 2020

Polymorphous ventricular tachycardia and atrioventricular block

1 reference

12 December 2020

Effects of activation sequence on the local recovery of ventricular excitability in the dog

1 reference

12 December 2020

Paradoxic response to disopyramide and quinidine (author's transl)

1 reference

12 December 2020

Torsade de pointes induced by sotalol and hypokalaemia

1 reference

12 December 2020

Fatal sotalol poisoning

1 reference

12 December 2020

Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin

1 reference

12 December 2020

Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication

1 reference

12 December 2020

Letter: Syncopes through the inversion of points in connection with the absorption of disopyramide

1 reference

12 December 2020

Invasive electrophysiological study in the Jervell and Lange-Nielsen syndrome

1 reference

12 December 2020

Prolongation of the Q-T interval caused by sotalol-Possible association with ventricular tachyarhythmias

1 reference

12 December 2020

Mexiletine for treatment of torsade de pointes

1 reference

12 December 2020

QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards

1 reference

12 December 2020

Amiodarone-induced torsades de pointes

1 reference

12 December 2020

True and false torsade de pointes

1 reference

12 December 2020

Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.

1 reference

12 December 2020

Selective intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage

1 reference

12 December 2020

Sudden death in phenothiazine therapy. (A clinicopathologic study of 12 cases).

1 reference

12 December 2020

Sotalol, prolonged Q-T interval, and ventricular tachyarrhythmias

1 reference

12 December 2020

Magnesium therapy for torsades de pointes

1 reference

12 December 2020

Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care

1 reference

12 December 2020

Recent advances in understanding the mechanisms of drug-induced torsades de pointes arrhythmias

1 reference

12 December 2020

Congenital complete heart block and long Q-T syndrome requiring ventricular pacing for control of refractory ventricular tachycardia and fibrillation

1 reference

12 December 2020

Fatal ventricular tachycardia in association with propafenone, a new class IC antiarrhythmic agent

1 reference

12 December 2020

Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients

1 reference

12 December 2020

Amiodarone induced torsades de pointe. Report of three cases and review of literature.

1 reference

12 December 2020

Cesium chloride-induced long QT syndrome: demonstration of afterdepolarizations and triggered activity in vivo

1 reference

12 December 2020

Reduction in QT dispersion by sotalol following myocardial infarction

1 reference

12 December 2020

Effects of pacing on triggered activity induced by early afterdepolarizations

1 reference

12 December 2020

Can antiarrhythmic drugs cause arrhythmia?

1 reference

12 December 2020

Amiodarone and torsade de pointes

1 reference

12 December 2020

QT interval prolongation and cardiac arrest during antibiotic therapy with spiramycin in a newborn infant.

1 reference

12 December 2020

When is QT prolongation antiarrhythmic and when is it proarrhythmic?

1 reference

12 December 2020

Torsade de pointes after astemizole overdose.

1 reference

12 December 2020

"Torsades de pointe" and reentry induced by anti-arrhythmia agents

1 reference

12 December 2020

Sotalol-induced torsade de pointes

1 reference

12 December 2020

Action potentials, afterpotentials, and arrhythmias

1 reference

12 December 2020

"T'orsade de pointe" and amiodarone (author's transl)

1 reference

12 December 2020

Management of recurrent ventricular tachyarrhythmias associated with Q-T prolongation

1 reference

12 December 2020

Adverse reaction to disopyramide

1 reference

12 December 2020

Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium

1 reference

12 December 2020

Blockade of current through single calcium channels by Cd2+, Mg2+, and Ca2+. Voltage and concentration dependence of calcium entry into the pore

1 reference

12 December 2020

Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy

1 reference

12 December 2020

Cellular electrophysiologic mechanisms of cardiac arrhythmias

1 reference

12 December 2020

Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris

1 reference

12 December 2020

Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia

1 reference

12 December 2020

Torsade de pointes. Mechanisms and management.

1 reference

12 December 2020

Disopyramide-Induced Ventricular Tachycardia

1 reference

12 December 2020

A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs

1 reference

12 December 2020

Proarrhythmic actions of antiarrhythmic drugs: a review

1 reference

12 December 2020

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis

1 reference

12 December 2020

Fatal torsade de pointes occurring in a patient receiving intravenous vasopressin and nitroglycerin

1 reference

12 December 2020

Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length

1 reference

12 December 2020

QT dispersion: an indication of arrhythmia risk in patients with long QT intervals

1 reference

12 December 2020

Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length.

1 reference

12 December 2020

10.2165/00002018-199411060-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1008954846

0 references

1 reference